Resources from the same session
Welcome and introduction
Presenter: George Demetri
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast
The patient perspective: The relevance of RWE in patient decision-making
Presenter: Renate Haidinger
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast
The regulator perspective: RWE and real-world data (RWD) in drug approvals and label expansions
Presenter: Jorge Camarero
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast
The payer perspective: Utilising RWD to determine the value of drugs
Presenter: Oriol Solà-Morales
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast
Panel discussion
Presenter: George Demetri, Jorge Camarero, Oriol Solà-Morales, Renate Haidinger
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast
Live Q&A - 24 September 2020 - 15:00-15:30
Presenter: George Demetri
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast